INNOVATIVE EYEWEAR, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price
INNOVATIVE EYEWEAR, INC. (LUCY) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price of $70.73 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice · last filed 2026-03-25
- INNOVATIVE EYEWEAR, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for the quarter ending 2024-03-31 was $1.27.
- INNOVATIVE EYEWEAR, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2025 was $70.73, a 49.44% increase from fiscal 2024.
- INNOVATIVE EYEWEAR, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2024 was $47.33, a 19.42% decline from fiscal 2023.
- INNOVATIVE EYEWEAR, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period, weighted average exercise price for fiscal 2023 was $58.74.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $70.73 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $70.73 10-Q · filed 2025-11-13 | ||||
| 2025-06-30 | $71.08 10-Q · filed 2025-08-14 | ||||
| 2024-12-31 | $47.33 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $42.13 10-Q · filed 2024-11-12 | ||||
| 2024-06-30 | $21.84 10-Q · filed 2024-08-12 | ||||
| 2024-03-31 | $1.27 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | $58.74 10-K · filed 2025-03-24 | $2.94 10-K · filed 2024-03-25 | |||
| 2023-09-30 | $2.94 10-Q · filed 2023-11-14 | ||||
| 2023-06-30 | $3.56 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |